Cargando…
Antithrombotic Agents and Cancer
Platelet activation is the first response to tissue damage and, if unrestrained, may promote chronic inflammation-related cancer, mainly through the release of soluble factors and vesicles that are rich in genetic materials and proteins. Platelets also sustain cancer cell invasion and metastasis for...
Autores principales: | Bruno, Annalisa, Dovizio, Melania, Tacconelli, Stefania, Contursi, Annalisa, Ballerini, Patrizia, Patrignani, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115803/ https://www.ncbi.nlm.nih.gov/pubmed/30065215 http://dx.doi.org/10.3390/cancers10080253 |
Ejemplares similares
-
Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System
por: Dovizio, Melania, et al.
Publicado: (2020) -
Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis
por: Rovati, Gianenrico, et al.
Publicado: (2022) -
P2Y(12) Receptors in Tumorigenesis and Metastasis
por: Ballerini, Patrizia, et al.
Publicado: (2018) -
The antiplatelet agent revacept prevents the increase of systemic thromboxane A(2) biosynthesis and neointima hyperplasia
por: Alberti, Sara, et al.
Publicado: (2020) -
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
por: Ballerini, Patrizia, et al.
Publicado: (2022)